TSI Group Co Ltd
603262.SS
Shanghai Stock Exchange25.00
CNY
-0.84
- -
ISIN
CNE1000074W9
Return %
Stock
S&P500
1Y
-38.65
21.04
3Y
-38.65
70.88
5Y
-38.65
73.53
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Jingshi Zhou
- Full Time Employees
- 687
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Address
- 1089 Qinzhou Road (N), Xuhui District, Shanghai, 20023, China Shanghai SH People's Republic of China 20023
- IPO Date
- Jul 23, 2025
- Website
- tsigroupltd.com
- Similar Companies
- Business
- TSI Group Co., Ltd. engages in the discovery, development, manufacturing, and sale of vitamins and dietary supplements for healthy lifestyles worldwide; it offers vegan glucosamine under the GlucosaGreen brand; ß-hydroxy ß-methylbutyrate under the myHMB brand; adenosine 5’- triphosphate under the PEAK ATP brand for body composition and athletic performance; 2-hydroxybenzylamine to support cellular health; enfinity, a downstream metabolite of caffeine; vitamins and dietary supplements under the FZZR and STRW brands; and glucosamine tablets under the OptiTab brand. The company operates across multiple global markets, with a focus on research and development, formulation, and scalable manufacturing of nutraceuticals and functional ingredients. Headquartered in Shanghai, China, it serves professional distributors, contract manufacturers, and direct-to-consumer channels, and concentrates on expanding its portfolio through targeted partnerships, product line extensions, and strategic collaborations to address growing consumer demand for dietary supplements and wellness solutions. Founded in 201? (founding year referenced in public profiles) and listed on the Shanghai Stock Exchange under ticker 603262.SS, TSI Group maintains a diversified product ecosystem, including branded nutraceuticals and OEM/ODM manufacturing capabilities to support global health and wellness brands. The company prioritizes quality assurance, compliance with international regulatory standards, and end-to-end supply chain integrity to service retailers, e-commerce platforms, and institutional customers across regions. Recent strategic activities include partnerships and potential portfolio expansions to accelerate market penetration in Europe, North America, and Asia, alongside ongoing investment in product innovations and capacity expansion to meet rising demand for scientifically formulated health solutions.